GINGER ROTHROCK, PHD

Director of Emerging Technologies and Commercialization

Ginger Rothrock is RTI’s Director of Commercialization, where she serves as Principal Investigator for a number of collaborative applied product development programs for polymer products in controlled-release systems, medical devices, and structural materials. She also manages RTI’s commercialization portfolio and sits on the steering committee for Translational and Clinical Sciences. Prior to working at RTI, Dr. Rothrock was a Co‐Founder and Principal Technologist of Liquidia Technologies, a mid‐stage biotechnology small business.